-
01
COMPANY PROFILE
公司概况
-
南京博天科智生物技术有限公司作为国内体外诊断试剂生产企业，前身由南京医科大学、江苏省人民医院及江苏省科教兴卫工程高技术平台学科梯队组建，是集研发、生产和销售于一体的高科技生物技术公司，着重于体外诊断产品的自主研发；产品主要涉及心血管疾病和恶性肿瘤领域等，获得多项国家级科技奖，国家发明及实用新型专利授权多项。
As a domestic manufacturer of in vitro diagnostic reagents, Nanjing Botian Kezhi Biotechnology co., ltd. was formerly established by Nanjing Medical University, Jiangsu Provincial People's Hospital and Jiangsu Province Science and Education Rehabilitation Engineering Hi-tech Platform discipline echelon.It is a high-tech biotechnology company integrating research and development, production and sales,focuses on the independent research and development of in vitro diagnostic products.The products are mainly related to cardiovascular diseases and malignant tumors, and have won a number of national science and technology awards, and many national invention and utility model patents.
-
02
COMPANY DEVELOPMENT
发展历史
-
2006年：公司成立；
2008年：获得医疗器械生产许可证；
2009-2012年：cTnI、H-FABP等产品相继上市；
2013-2016年：开展无创体外诊断试剂的研发；
2017年：获得天使基金；
2018年：无创体外诊断产品临床试验及注册；
2019年：公司重组，引进战略投资人；
2021年：获得国家高新技术企业称号
The company was established in 2006;
obtained a medical device production license in 2008;
cTnI, H-FABP and other products were successively marketed from 2009 to 2012;
R & D of non-invasive in vitro diagnostic reagents was carried out from 2013 to 2016;
angel fund was obtained in 2017;
Clinical trials and registration of diagnostic products in 2018;
company restructuring and introduction of strategic investors in 2019.
Won the title of national high-tech enterprise in 2021
-
03
COMPANY CULTURE
企业文化
-
我们的宗旨：科学创新、厚积薄发、严密质控、服务至上
我们的理念：无创、快速、精准
我们的使命：专业、呵护生命Our aim: scientific innovation, accumulation of wealth, strict quality control, service first
Our philosophy: non-invasive, fast and accurate
Our mission: professional, care for life